Spruce Biosciences
SPRB | NASDAQ
$42.25
-$1.06 (-2.45%)
At close: Nov 16, 2026, 4:00 PM ET
$42.25
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-2.45%
(1D)No price chart data available for 1D timeframe.
Rating
28.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #848/1021 (Top 83%)
Key Statistics
Market Data
Market Cap $121.43M
1D Range
41.56 45.04
52W Range
38.98 115.00
Valuation (TTM)
PE -1.21
PB 1.83
EV/EBITDA -0.67
Valuation (NTM)
Forward PE 51.79
Forward PEG -0.03
Price Target $149.00
Cash Flow
FCF Yield -42.2%
SBC Adj. FCF Yield -45.8%
SBC Impact -8.5%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -136.6% |
-21.7%
Dil EPS 3Y | 5Y 29.0% |
11.0%
FCF 3Y | 5Y -4.9% |
-8.4%
Returns
ROA -73.0%
ROE -118.2%
ROIC -82.0%
Financial Health
Net Cash
$79.87M
Current Ratio 4.83
Interest Coverage -21.35
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Spruce Biosciences, Inc., founded in 2014 and situated in Daly City, California, operates as a biopharmaceutical enterprise. Its primary objective is to advance and bring to market innovative treatmen...
Sector Healthcare
Industry Biotechnology
Employees 22
IPO Date Oct 9, 2020
Website www.sprucebio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$149.00
Upside
+252.66%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove SPRB